These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 25242631)
1. High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS. Jurewicz A; Zaleski K; Domowicz M; Selmaj K J Neuroimmunol; 2014 Nov; 276(1-2):187-94. PubMed ID: 25242631 [TBL] [Abstract][Full Text] [Related]
2. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE. Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785 [TBL] [Abstract][Full Text] [Related]
3. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes. Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948 [TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables. Putheti P; Morris M; Stawiarz L; Teleshova N; Kivisäkk P; Pashenkov M; Kouwenhoven M; Wiberg MK; Bronge L; Huang YM; Söderström M; Hillert J; Link H Eur J Neurol; 2003 Sep; 10(5):529-35. PubMed ID: 12940835 [TBL] [Abstract][Full Text] [Related]
5. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate. Høglund RA; Hestvik AL; Holmøy T; Maghazachi AA Hum Immunol; 2011 Feb; 72(2):124-34. PubMed ID: 20977917 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis. Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233 [TBL] [Abstract][Full Text] [Related]
7. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection. Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329 [TBL] [Abstract][Full Text] [Related]
8. ALCAM and CD6--multiple sclerosis risk factors. Wagner M; Bilinska M; Pokryszko-Dragan A; Sobczynski M; Cyrul M; Kusnierczyk P; Jasek M J Neuroimmunol; 2014 Nov; 276(1-2):98-103. PubMed ID: 25216742 [TBL] [Abstract][Full Text] [Related]
9. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Haringman JJ; Smeets TJ; Reinders-Blankert P; Tak PP Ann Rheum Dis; 2006 Mar; 65(3):294-300. PubMed ID: 16107514 [TBL] [Abstract][Full Text] [Related]
10. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions. Mahad DJ; Trebst C; Kivisäkk P; Staugaitis SM; Tucky B; Wei T; Lucchinetti CF; Lassmann H; Ransohoff RM J Neuropathol Exp Neurol; 2004 Mar; 63(3):262-73. PubMed ID: 15055450 [TBL] [Abstract][Full Text] [Related]
11. Chemokine receptors and early activation markers in acute anterior uveitis. Klitgaard TL; Øgard C; Krogh E Acta Ophthalmol Scand; 2004 Apr; 82(2):179-83. PubMed ID: 15043537 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester. Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228 [TBL] [Abstract][Full Text] [Related]
13. CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. Kantarci OH; Morales Y; Ziemer PA; Hebrink DD; Mahad DJ; Atkinson EJ; Achenbach SJ; De Andrade M; Mack M; Ransohoff RM; Lassmann H; Bruck W; Weinshenker BG; Lucchinetti CF J Neuroimmunol; 2005 Dec; 169(1-2):137-43. PubMed ID: 16182378 [TBL] [Abstract][Full Text] [Related]
14. Distinct chemokine receptor and cytokine expression profile in secondary progressive MS. Sørensen TL; Sellebjerg F Neurology; 2001 Oct; 57(8):1371-6. PubMed ID: 11673573 [TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor expression in peripheral blood monocytes from patients with neovascular age-related macular degeneration. Grunin M; Burstyn-Cohen T; Hagbi-Levi S; Peled A; Chowers I Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5292-300. PubMed ID: 22789920 [TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury. Fox RJ; Kivisakk P; Fisher E; Tucky B; Lee JC; Rudick RA; Ransohoff RM Mult Scler; 2008 Sep; 14(8):1036-43. PubMed ID: 18701575 [TBL] [Abstract][Full Text] [Related]
17. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation. Kofler DM; Severson CA; Mousissian N; De Jager PL; Hafler DA J Immunol; 2011 Sep; 187(6):3286-91. PubMed ID: 21849685 [TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis. Shahrara S; Amin MA; Woods JM; Haines GK; Koch AE Arthritis Rheum; 2003 Dec; 48(12):3568-83. PubMed ID: 14674010 [TBL] [Abstract][Full Text] [Related]
19. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis. Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738 [TBL] [Abstract][Full Text] [Related]
20. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis. Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]